Prandial Options to Advance Basal Insulin Glargine Therapy: Testing Lixisenatide Plus Basal Insulin Versus Insulin Glulisine Either as Basal-Plus or Basal-Bolus in Type 2 Diabetes: The GetGoal Duo-2 Trial. (Q51284082)
Jump to navigation
Jump to search
scientific article published on 23 May 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Prandial Options to Advance Basal Insulin Glargine Therapy: Testing Lixisenatide Plus Basal Insulin Versus Insulin Glulisine Either as Basal-Plus or Basal-Bolus in Type 2 Diabetes: The GetGoal Duo-2 Trial. |
scientific article published on 23 May 2016 |
Statements
1 reference
Prandial Options to Advance Basal Insulin Glargine Therapy: Testing Lixisenatide Plus Basal Insulin Versus Insulin Glulisine Either as Basal-Plus or Basal-Bolus in Type 2 Diabetes: The GetGoal Duo-2 Trial. (English)
1 reference
1 reference
Markolf Hanefeld
1 reference
Julio Rosenstock
1 reference
Bruno Guerci
1 reference
Sandro Gentile
1 reference
Ronnie Aronson
1 reference
Christine Roy-Duval
1 reference
Elisabeth Souhami
1 reference
Marek Wardecki
1 reference
Jenny Ye
1 reference
Riccardo Perfetti
1 reference
GetGoal Duo-2 Trial Investigators
1 reference
23 May 2016
1 reference
1 reference
39
1 reference
8
1 reference
1318-1328
1 reference
Identifiers
1 reference
1 reference